Medexus Pharmaceuticals (MDP) News Today → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free MDP Stock Alerts C$7.75 -0.40 (-4.91%) (As of 06/16/2021) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWith A Return On Equity Of 20%, Has Medexus Pharmaceuticals Inc.'s (TSE:MDP) Management Done Well?finance.yahoo.com - May 8 at 3:25 PMMedexus Pharmaceuticals Inc (P731.BE)au.finance.yahoo.com - February 13 at 3:04 AMMedexus Pharmaceuticals Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Nextfinance.yahoo.com - February 10 at 9:52 AMMedexus Schedules Third Fiscal Quarter 2024 Conference Callfinance.yahoo.com - January 30 at 7:48 AMBoasting A 23% Return On Equity, Is Medexus Pharmaceuticals Inc. (TSE:MDP) A Top Quality Stock?finance.yahoo.com - November 30 at 8:41 AMMedexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 Millionfinance.yahoo.com - November 8 at 5:57 PMMedexus Schedules Second Fiscal Quarter 2024 Conference Callfinance.yahoo.com - November 1 at 7:39 AMCanadian Investment Regulatory Organization Trading Halt - MDP.DBfinance.yahoo.com - October 16 at 8:46 AMMedexus Pharmaceuticals' (TSE:MDP) earnings growth rate lags the 131% return delivered to shareholdersfinance.yahoo.com - October 11 at 9:19 AMMedexus Announces Closing of C$10 Million Bought-Deal Public Offeringfinance.yahoo.com - October 6 at 10:14 AMShareholders May Be More Conservative With Medexus Pharmaceuticals Inc.'s (TSE:MDP) CEO Compensation For Nowfinance.yahoo.com - September 15 at 8:06 AMMedexus Pharmaceuticals (MEDXF) Price Target Increased by 16.36% to 3.18msn.com - August 31 at 4:29 AMClosing Bell: Medexus Pharmaceuticals Inc up on Wednesday (MDP)theglobeandmail.com - August 23 at 11:52 PMHere's Why We Think Medexus Pharmaceuticals (TSE:MDP) Is Well Worth Watchingfinance.yahoo.com - August 19 at 4:55 PMMedexus Pharmaceuticals Inc (MDP) Gets a Buy Rating from Stifel Nicolausmarkets.businessinsider.com - July 13 at 12:10 PMMedexus Pharmaceuticals Inc (MDP) Receives a Buy from Echelon Wealth Partnersmarkets.businessinsider.com - June 22 at 12:41 PMMedexus Pharmaceuticals Inc.: Medexus Generates Record Revenue of Us$108.1 Million in Fiscal Year 2023finanznachrichten.de - June 21 at 8:21 PMMedexus Generates Record Revenue of US$108.1 Million in Fiscal Year 2023finance.yahoo.com - June 21 at 8:21 PMMedexus Highlights Data on Trecondyv (Treosulfan) Presented at MDS 2023finance.yahoo.com - June 13 at 8:50 AMMedexus Demonstrates Cost-Effectiveness of Gleolan-Guided Surgery for High-Grade Gliomafinance.yahoo.com - May 9 at 9:09 PMClosing Bell: Medexus Pharmaceuticals Inc down on Tuesday (MDP)theglobeandmail.com - May 3 at 3:44 PMMedexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 18 at 5:47 PMClosing Bell: Medexus Pharmaceuticals Inc down on Thursday (MDP)theglobeandmail.com - April 14 at 7:37 PMClosing Bell: Medexus Pharmaceuticals Inc down on Wednesday (MDP)theglobeandmail.com - April 13 at 12:39 AMClosing Bell: Medexus Pharmaceuticals Inc up on Tuesday (MDP)theglobeandmail.com - April 12 at 2:38 PMClosing Bell: Medexus Pharmaceuticals Inc up on Thursday (MDP)theglobeandmail.com - April 7 at 6:04 PMClosing Bell: Medexus Pharmaceuticals Inc WT flat on Thursday (MDP-WT)theglobeandmail.com - April 7 at 1:04 PMClosing Bell: Medexus Pharmaceuticals Inc up on Friday (MDP)theglobeandmail.com - April 2 at 7:23 PMMedexus Announces US$58.5 million in New Credit Facilitiesfinance.yahoo.com - March 8 at 6:52 PMMedexus Announces US$58.5 million in New Credit Facilitiesfinance.yahoo.com - March 8 at 6:52 PMIIROC Trading Halt - MDP.WTfinance.yahoo.com - February 23 at 3:35 PMMedexus Welcomes Two New Board Membersfinance.yahoo.com - February 6 at 5:54 PMMedexus Schedules Third Fiscal Quarter 2023 Conference Callfinance.yahoo.com - January 31 at 6:25 PMMedexus Schedules First Quarter 2023 Conference Callfinance.yahoo.com - August 2 at 7:44 PMTreosulfan NDA Resubmitted to FDAfinance.yahoo.com - July 25 at 7:43 AMTreosulfan Pivotal Study Results Publishedfinance.yahoo.com - June 6 at 10:48 AMMedexus Pharmaceuticals Provides Update on Resubmission of Treosulfan NDAfinance.yahoo.com - May 24 at 5:16 PMMedexus to Participate in the 34th Annual Roth Conferencefinance.yahoo.com - March 9 at 8:23 AMMedexus Pharmaceuticals Announces Deal for Gleolan in the United Statesfinance.yahoo.com - March 1 at 10:21 AMRaymond James Initiates Coverage On Medexus Pharmaceuticals with Outperform Rating, Announces Price Target of C$5.5benzinga.com - February 22 at 3:43 PMMedexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debenturesnz.finance.yahoo.com - February 15 at 8:47 PMMedexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debenturesfinance.yahoo.com - February 14 at 8:09 AMLoss-making Medexus Pharmaceuticals (TSE:MDP) has seen earnings and shareholder returns follow the same downward trajectory over past -63%finance.yahoo.com - February 8 at 1:02 PMMedexus to Present at The MicroCap Rodeo’s 2nd Annual Winter Wonderland Best Ideas Investor Conferencefinance.yahoo.com - February 1 at 4:24 PMWould it Be Fine if You Invest in Medexus Pharmaceuticals (MDP)?finance.yahoo.com - December 16 at 9:33 AMMedexus to Participate in Two Upcoming Virtual Investor Conferencesfinance.yahoo.com - December 2 at 6:16 PMStocks in play: Medexus Pharmaceuticals Inc.ca.finance.yahoo.com - November 10 at 6:01 PMMedexus Pharmaceuticals Reports Financial and Operational Results for the Three- and Six-Month Periods Ending September 30, 2021finance.yahoo.com - November 10 at 6:01 PMMedexus Schedules Second Quarter Fiscal 2022 Conference Callfinance.yahoo.com - November 4 at 9:01 AMPhama Company Shares Rise Ahead of FDA Reviewbaystreet.ca - November 1 at 2:14 PM Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. MDP Media Mentions By Week MDP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDP News Sentiment▼0.710.58▲Average Medical News Sentiment MDP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDP Articles This Week▼10▲MDP Articles Average Week Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HLS News CRDL News RX News CPH News DB News OGI News CWEB News ACB News ZEN News EDT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:MDP) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
